Propofol-Remifentanil Dosing for Deep Sedation
For deep sedation in adults, initiate remifentanil at 0.125 µg/kg/min for 2 minutes, then reduce to 0.05 µg/kg/min continuous infusion, combined with propofol boluses of 10-20 mg every 20-30 seconds until target sedation is achieved. 1
Initial Dosing Regimen
Remifentanil:
- Start at 0.125 µg/kg/min for 2 minutes 1
- Reduce to maintenance infusion of 0.05 µg/kg/min 1
- For general anesthesia induction, remifentanil 0.5-1 mcg/kg/min is recommended 2
Propofol:
- Administer 10-20 mg boluses every 20-30 seconds 1
- Allow sufficient time between doses for peak effect assessment before additional administration 1
- For ICU sedation, initiate at 5 mcg/kg/min (0.3 mg/kg/h) and increase by 5-10 mcg/kg/min increments 3
Critical Dosing Adjustments
Reduce propofol doses by 50-75% from monotherapy doses when combining with remifentanil due to synergistic effects. 1 This is essential because the combination produces respiratory depression beyond either agent alone 1. The FDA label confirms that remifentanil is synergistic with propofol, requiring up to 75% dose reduction of propofol when coadministered 2.
Titration strategy:
- Propofol: 5-15 mg boluses 1
- Remifentanil: adjust infusion by 25-50% every 2-5 minutes 1
- Maintenance propofol typically ranges 5-50 mcg/kg/min (0.3-3 mg/kg/h) 3
- Maintenance remifentanil typically 0.4-1.0 mcg/kg/min for deep sedation 2
Alternative Approach: Target-Controlled Infusion
The Difficult Airway Society specifically recommends avoiding bolus dosing for both agents and instead using target-controlled infusion with: 1
This approach significantly reduces apnea incidence compared to manual bolus administration 1. Research demonstrates that automated TCI administration maintains deep sedation (BIS 40-60) 77% of the time versus only 36% with manual administration, while reducing propofol consumption by 50% 4.
Mandatory Safety Monitoring
Continuous monitoring requirements include: 1
- Pulse oximetry 1
- Blood pressure and heart rate 1
- Capnography for early hypoventilation detection 1
- Dedicated healthcare provider performing no other tasks 1
- Supplemental oxygen administration (mandatory) 1
- Maintained vascular access throughout procedure 1
Critical Safety Warnings
The combination produces synergistic respiratory depression with significantly increased risk of apnea and hypoxemia. 1 Research confirms apnea incidence increases from 15% with remifentanil alone to 52% when combined with propofol 5. Severe desaturation occurred in 0.6% and significant desaturation in 1.6% of procedures using this combination 6.
Propofol provides zero analgesic properties—remifentanil is essential for painful procedures. 1 This is a common pitfall: propofol only provides sedation and amnesia, not analgesia 1.
Hemodynamic effects:
- Propofol causes dose-dependent decreases in cardiac output, systemic vascular resistance, and arterial pressure 7
- Significant hypotension occurs in 8.8% of cases 6
- Elderly and ASA III-IV patients have exaggerated hemodynamic responses to rapid boluses 3
Patient-Specific Adjustments
Age and BMI considerations: 6
- Higher BMI: use lower maximum propofol concentrations and increases desaturation risk 6
- Increased age: use lower propofol doses and increases hypotension risk 6
- Elderly patients: reduce initial propofol bolus to 10-15 mg 7
For hemodynamically unstable patients:
- Avoid loading doses of remifentanil 2
- Administer propofol loading dose only if hypotension unlikely 8
- Consider reducing doses by additional 25-50% beyond standard combination reduction 1
Reversal and Equipment Requirements
Have immediately available: 1
- Naloxone for remifentanil reversal 1
- Airway management equipment including bag-mask ventilation 9
- Equipment for endotracheal intubation 9
Common Pitfalls to Avoid
- Rapid administration: Slow titration is essential to avoid hypotension and respiratory depression 9
- Inadequate pain management during emergence: Remifentanil's rapid offset results in greater pain incidence (13.5% vs 5.1% with fentanyl), requiring proactive transition to longer-acting analgesics 10
- Targeting deep sedation when not indicated: Target moderate rather than deep sedation when possible to improve safety profile 1
- Insufficient monitoring: The combination requires more intensive monitoring than either agent alone due to synergistic effects 1
- Propofol infusion syndrome risk: Do not exceed 4 mg/kg/hour propofol unless benefits outweigh risks 3